https://assets.capyfin.com/instruments/678fdc13234e27009c5d5b84.png avatar
ResMed
🇺🇸 NYSE:RMD
•
Dec 31, 2024

ResMed Q2 2025 Earnings Report

Total Revenue
$1.28B
Previous year: $1.16B
+10.2%
EPS
$2.43
Previous year: $1.88
+29.3%
Gross Profit
$751M
Previous year: $647M
+16.1%
Cash and Equivalents
$522M
Previous year: $210M
+148.3%
Free Cash Flow
$288M
Previous year: $249M
+15.4%
Total Assets
$7.14B
Previous year: $6.91B
+3.4%

ResMed Revenue

ResMed EPS

ResMed Revenue by Segment

Revenue & Expenses

Visualization of income flow from segment revenue to net income